Jéssica Thayssa Ferreira de Almeida
Research Subjects
Jéssica Thayssa Ferreira de Almeida has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Alexandre Bento Barbosa
Medicina, Universidade Anhanguera Uniderp
1 shared publication- Ana Alves Oliveira
Pathology Department, Hospital Garcia de Orta, Av. Torrado da Silva, 2805-267, Almada, Portugal
1 shared publication - Ana Cristina Santos
Universidade do Porto, Portugal
1 shared publication Dener Rocha Moreira
Medicina, Universidade Anhanguera Uniderp
1 shared publication- F. Viveiros
Unidade de Broncologia, Serviço de Pneumologia, Centro Hospitalar de Gaia/Espinho
1 shared publication - Isabela Kemp Chacarosque Gonçalves
Medicina, Universidade Anhanguera Uniderp
1 shared publication
Latest Publications
- Open Access
- 14 July 2023
- Published by Instituto de Administração e Gestão Educacional Ltda in Revista Master - Ensino, Pesquisa e Extensão
- Vol. 8 (15)
Análise do perfil do uso de agrotóxicos no estado do Mato Grosso Do Sul, políticas públicas relacionadas e impactos na saúde da população.
O presente estudo buscou retratar o uso de agrotóxicos no estado do Mato Grosso do Sul, assim como abordar as questões legislativas que dão o suporte para seu consumo e distribuição. Foram analisados diversos artigos com intuito de comparar como os agrotóxicos mais utilizados no contexto estadual poderiam influenciar na saúde da população. Observou-se que mesmo com as legislações vigentes ainda há uso exacerbado de agrotóxicos de alta toxidade que são proibidos em outros países. Nesse contexto, surge a importância deste estudo para a saúde da população, oferecendo subsídios epidemiológicos aos profissionais de saúde para o diagnóstico precoce das intoxicações agudas e das consequências crônicas, principalmente relacionadas à população rural que trabalha diretamente com estes produtos. Possibilita, também, o devido suporte aos profissionais ambientais, procurando motivá-los a buscar meios alternativos para garantir a continuidade do crescimento da produtividade da agricultura no Estado, setor que é estratégico da sua economia, com base em princípios da sustentabilidade ambiental e de prevenção e promoção da saúde coletiva. Diante deste cenário, cabe levantarmos o questionamento de como equilibrar produções agrícolas eficientes e a segurança da população, visto que Mato Grosso do Sul é o Estado que mais utiliza agrotóxicos na agricultura, num país que lidera os rankings mundiais.
- 14 July 2023
- Published by Instituto de Administração e Gestão Educacional Ltda in Revista Master - Ensino, Pesquisa e Extensão
- Vol. 8 (15)
Open AccessAnálise do perfil do uso de agrotóxicos no estado do Mato Grosso Do Sul, políticas públicas relacionadas e impactos na saúde da população.
O presente estudo buscou retratar o uso de agrotóxicos no estado do Mato Grosso do Sul, assim como abordar as questões legislativas que dão o suporte para seu consumo e distribuição. Foram analisados diversos artigos com intuito de comparar como os agrotóxicos mais utilizados no contexto estadual poderiam influenciar na saúde da população. Observou-se que mesmo com as legislações vigentes ainda há uso exacerbado de agrotóxicos de alta toxidade que são proibidos em outros países. Nesse contexto, surge a importância deste estudo para a saúde da população, oferecendo subsídios epidemiológicos aos profissionais de saúde para o diagnóstico precoce das intoxicações agudas e das consequências crônicas, principalmente relacionadas à população rural que trabalha diretamente com estes produtos. Possibilita, também, o devido suporte aos profissionais ambientais, procurando motivá-los a buscar meios alternativos para garantir a continuidade do crescimento da produtividade da agricultura no Estado, setor que é estratégico da sua economia, com base em princípios da sustentabilidade ambiental e de prevenção e promoção da saúde coletiva. Diante deste cenário, cabe levantarmos o questionamento de como equilibrar produções agrícolas eficientes e a segurança da população, visto que Mato Grosso do Sul é o Estado que mais utiliza agrotóxicos na agricultura, num país que lidera os rankings mundiais.
- Open Access
- 30 November 2013
- Published by Taylor & Francis in Pulmonology
- Vol. 19 (6) , 276-280
Aplicação tópica de mitomicina-C como adjuvante no tratamento broncoscópico da estenose traqueal pós-entubação
Post-intubation tracheal stenosis (PITS) continues to be challenging in terms of diagnosis, management and prevention. Recurrence is common because of excessive granulation tissue formation and an insidious process of scar contracture. Topical application of mitomycin-C (MMC) as an adjuvant treatment for endoscopic management of stenosis has shown good results. The authors aimed to evaluate the results of MMC topical application following bronchoscopic dilatation as an adjuvant in PITS treatment. Retrospectively selected patients with PITS who had had rigid bronchoscopy (RB) dilatation followed by MMC application as adjuvant to endoscopic treatment. MMC in a concentration of 0.4 mg/ml was applied with a cotton stiletto around the stenotic lesion and granulation tissue for 3 minutes. Eleven patients with PITS, with a median initial tracheal stenosis of 75% of the lumen, underwent RB/MMC treatment. Mean MMC sessions performed/patient was 3.5, with good response and prolonged decrease in granulation tissue formation in 55% of cases, moderate in 18% and relapse in 27%. Mean stenosis improvement was 34%. Topical MMC application at 0.4 mg/ml concentration seems to be associated with good results as adjuvant in PITS management with decrease in granulation tissue and sustained improvement in lumen diameter.
- 30 November 2013
- Published by Taylor & Francis in Pulmonology
- Vol. 19 (6) , 276-280
Open AccessAplicação tópica de mitomicina-C como adjuvante no tratamento broncoscópico da estenose traqueal pós-entubação
Post-intubation tracheal stenosis (PITS) continues to be challenging in terms of diagnosis, management and prevention. Recurrence is common because of excessive granulation tissue formation and an insidious process of scar contracture. Topical application of mitomycin-C (MMC) as an adjuvant treatment for endoscopic management of stenosis has shown good results. The authors aimed to evaluate the results of MMC topical application following bronchoscopic dilatation as an adjuvant in PITS treatment. Retrospectively selected patients with PITS who had had rigid bronchoscopy (RB) dilatation followed by MMC application as adjuvant to endoscopic treatment. MMC in a concentration of 0.4 mg/ml was applied with a cotton stiletto around the stenotic lesion and granulation tissue for 3 minutes. Eleven patients with PITS, with a median initial tracheal stenosis of 75% of the lumen, underwent RB/MMC treatment. Mean MMC sessions performed/patient was 3.5, with good response and prolonged decrease in granulation tissue formation in 55% of cases, moderate in 18% and relapse in 27%. Mean stenosis improvement was 34%. Topical MMC application at 0.4 mg/ml concentration seems to be associated with good results as adjuvant in PITS management with decrease in granulation tissue and sustained improvement in lumen diameter.
- Open Access
- 31 January 2012
- Published by Taylor & Francis in Pulmonology
- Vol. 18 (1) , 15-21
Prevalência de insónia de novo em doentes com síndrome de apneia obstrutiva do sono tratados com suporte ventilatório nocturno
New-onset insomnia (NOI) associated with nocturnal ventilatory support (NVS) is becoming a reality in clinical practice; however there is a lack of data about its prevalence. Our aim was to determine the prevalence of NOI in patients with obstructive sleep apnoea syndrome (OSAS) under NVS and its associated risk factors. Descriptive cross-sectional study of 80 patients with OSAS under NVS. We compared two groups, with and without NOI, considering demographic characteristics, disease features, and personality. Patients under anxiolytic and/or antidepressant medication, with a weight loss of 10% or greater, and with restless legs symptoms were excluded. Median age of patients was 60.0 (interquartile range (IQR) 10.0) years; 82.5% were male. Median initial Epworth Sleepiness Scale (ESS) and apnoea-hypopnoea index (AHI) were 12.5 (IQR 9.0) and 44.1 (IQR 22.4)/hr, respectively. The majority of patients (91.3%) were under auto-adjusting positive airway pressure (APAP). Insomnia at baseline was present in 30% of patients (n=24). Prevalence of NOI was 21.4% (12/56). Initial and/or intermediate insomnia were the most frequent subtypes (n=11). We found a statistically significant negative relation between NOI and pressure on 90% night-time (P(90)) (p=0.040). OSAS patients under NVS presented a high prevalence of NOI. Patients with NOI presented lower levels of pressure using NVS, compared to the others.
- 31 January 2012
- Published by Taylor & Francis in Pulmonology
- Vol. 18 (1) , 15-21
Open AccessPrevalência de insónia de novo em doentes com síndrome de apneia obstrutiva do sono tratados com suporte ventilatório nocturno
New-onset insomnia (NOI) associated with nocturnal ventilatory support (NVS) is becoming a reality in clinical practice; however there is a lack of data about its prevalence. Our aim was to determine the prevalence of NOI in patients with obstructive sleep apnoea syndrome (OSAS) under NVS and its associated risk factors. Descriptive cross-sectional study of 80 patients with OSAS under NVS. We compared two groups, with and without NOI, considering demographic characteristics, disease features, and personality. Patients under anxiolytic and/or antidepressant medication, with a weight loss of 10% or greater, and with restless legs symptoms were excluded. Median age of patients was 60.0 (interquartile range (IQR) 10.0) years; 82.5% were male. Median initial Epworth Sleepiness Scale (ESS) and apnoea-hypopnoea index (AHI) were 12.5 (IQR 9.0) and 44.1 (IQR 22.4)/hr, respectively. The majority of patients (91.3%) were under auto-adjusting positive airway pressure (APAP). Insomnia at baseline was present in 30% of patients (n=24). Prevalence of NOI was 21.4% (12/56). Initial and/or intermediate insomnia were the most frequent subtypes (n=11). We found a statistically significant negative relation between NOI and pressure on 90% night-time (P(90)) (p=0.040). OSAS patients under NVS presented a high prevalence of NOI. Patients with NOI presented lower levels of pressure using NVS, compared to the others.